X-FAB Silicon Foundries (XFAB) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
1 Sep, 2026Executive summary
Q2 2026 revenue ranged from $196.0M to $199.8M, down 7–10% year-over-year but up 2% sequentially, with bookings and backlog showing signs of recovery and core markets (automotive, industrial, medical) making up 93% of revenue.
Automotive bookings improved sequentially, while medical revenue grew 39% year-over-year and 9% quarter-over-quarter; industrial and automotive segments declined.
EBITDA was $33.6M (16.8% margin), down 35% year-over-year; EBIT was $2.1M, down 90% year-over-year; net loss was $14.8M, impacted by a non-cash tax asset derecognition in Malaysia.
Strategic focus on AI-driven data center infrastructure, photonics, and wide bandgap technologies is accelerating, with several new design wins.
Internal reorganization introduced three business units to enhance alignment with customer needs and strategic focus.
Financial highlights
Gross profit for Q2 was $30.5M (15.3% margin), EBITDA $33.6M (16.8% margin), EBIT $2.1M (1.0% margin); net loss of $14.8M included a $11.0M non-cash tax asset derecognition.
Cash and cash equivalents at quarter-end were $163.6M; net debt increased to $312.3M, up $20.9M sequentially.
CapEx for Q2 was $24.2M; H1 2026 CapEx totaled $50.2M.
Prototyping revenue was $17.7M, down 16% year-over-year and 7% quarter-over-quarter.
Net cash from operating activities was $30.6M in Q2; net cash used in investing was $13.4M.
Outlook and guidance
Q3 2026 revenue expected between $195M–$205M, with EBITDA margin guidance of 17–20%.
Management anticipates a stronger second half versus first half, with recovery expected to continue into Q4, though no formal Q4 guidance provided.
Cost-saving program initiated, with results expected by end of 2026.
Long-term revenue potential for data center applications estimated at $300M annually.
Latest events from X-FAB Silicon Foundries
- Q1 2026 revenue was $195.6M, with strong growth in industrial, medical, and microsystems.XFAB
Q1 2026 - Q4 revenue up 18% YoY to $222.3M; industrial and medical growth offset automotive softness.XFAB
Q4 2025 - Q3 2025 revenue up 12% YoY to $229M, led by industrial and medical growth; order intake fell.XFAB
Q3 2025 - Three-pillar strategy and $1.1B expansion drive growth in specialty semiconductors.XFAB
Investor Day 2025 - Q2 revenue up 5–8% year-over-year, guidance raised, and capacity expansion completed.XFAB
Q2 2025 - Double-digit growth, major expansions, and $1.5B revenue and 35% margin targeted by 2030.XFAB
Investor Day 2024 - Q3 revenue up sequentially, automotive strong, industrial/medical weak, guidance lowered.XFAB
Q3 2024 - Q2 revenue fell 9% year-on-year; SiC weakness led to lower guidance, but Q4 rebound expected.XFAB
Q2 2024 - Q4 2024 revenue and profit fell amid auto destocking; CapEx to drop and recovery expected in 2025.XFAB
Q4 2024